Computational Simulation of Exosome Transport in Tumor Microenvironment.

Roy Koomullil, Behnam Tehrani, Kayla Goliwas, Yong Wang, Selvarangan Ponnazhagan, Joel Berry, Jessy Deshane
Author Information
  1. Roy Koomullil: Department of Mechanical Engineering, University of Alabama at Birmingham, Birmingham, AL, United States.
  2. Behnam Tehrani: Department of Mechanical Engineering, University of Alabama at Birmingham, Birmingham, AL, United States.
  3. Kayla Goliwas: Department of Medicine, Division of Pulmonary Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
  4. Yong Wang: Department of Medicine, Division of Pulmonary Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
  5. Selvarangan Ponnazhagan: Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
  6. Joel Berry: Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, United States.
  7. Jessy Deshane: Department of Medicine, Division of Pulmonary Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

Abstract

Cellular exosome-mediated crosstalk in tumor microenvironment (TME) is a critical component of anti-tumor immune responses. In addition to particle size, exosome transport and uptake by target cells is influenced by physical and physiological factors, including interstitial fluid pressure, and exosome concentration. These variables differ under both normal and pathological conditions, including cancer. The transport of exosomes in TME is governed by interstitial flow and diffusion. Based on these determinants, mathematical models were adapted to simulate the transport of exosomes in the TME with specified exosome release rates from the tumor cells. In this study, the significance of spatial relationship in exosome-mediated intercellular communication was established by treating their movement in the TME as a continuum using a transport equation, with advection due to interstitial flow and diffusion due to concentration gradients. To quantify the rate of release of exosomes by biomechanical forces acting on the tumor cells, we used a transwell platform with confluent triple negative breast cancer cells 4T1.2 seeded in BioFlex plates exposed to an oscillatory force. Exosome release rates were quantified from 4T1.2 cells seeded at the bottom of the well following the application of either no force or an oscillatory force, and these rates were used to model exosome transport in the transwell. The simulations predicted that a larger number of exosomes reached the membrane of the transwell for 4T1.2 cells exposed to the oscillatory force when compared to controls. Additionally, we simulated the interstitial fluid flow and exosome transport in a 2-dimensional TME with macrophages, T cells, and mixtures of these two populations at two different stages of a tumor growth. Computational simulations were carried out using the commercial computational simulation package, ANSYS/Fluent. The results of this study indicated higher exosome concentrations and larger interstitial fluid pressure at the later stages of the tumor growth. Quantifying the release of exosomes by cancer cells, their transport through the TME, and their concentration in TME will afford a deeper understanding of the mechanisms of these interactions and aid in deriving predictive models for therapeutic intervention.

Keywords

References

  1. Biomaterials. 2017 Oct;142:1-12 [PMID: 28715655]
  2. Cells. 2020 May 24;9(5): [PMID: 32456301]
  3. Lab Invest. 2020 Dec;100(12):1503-1516 [PMID: 32572176]
  4. Mol Pharm. 2019 Jan 7;16(1):24-40 [PMID: 30513203]
  5. Converg Sci Phys Oncol. 2017;3: [PMID: 30079253]
  6. Nature. 2015 Nov 19;527(7578):329-35 [PMID: 26524530]
  7. Cancer Cell. 2016 Dec 12;30(6):836-848 [PMID: 27960084]
  8. PLoS One. 2013 Nov 28;8(11):e82382 [PMID: 24312418]
  9. Brief Bioinform. 2016 May;17(3):408-18 [PMID: 25810307]
  10. Nat Med. 2012 Jun;18(6):883-91 [PMID: 22635005]
  11. PLoS One. 2013 Aug 05;8(8):e70395 [PMID: 23940570]
  12. Exp Biol Med (Maywood). 2010 Apr;235(4):411-23 [PMID: 20407073]
  13. Sci Rep. 2016 Apr 18;6:24436 [PMID: 27087234]
  14. Front Oncol. 2013 Mar 05;3:44 [PMID: 23467856]
  15. J Biotechnol. 2013 May 20;165(2):77-84 [PMID: 23562828]
  16. Oncotarget. 2016 Nov 15;7(46):75407-75424 [PMID: 27705910]
  17. Cell Commun Signal. 2018 Apr 24;16(1):17 [PMID: 29690889]
  18. JCO Clin Cancer Inform. 2019 Feb;3:1-13 [PMID: 30715927]
  19. Oncotarget. 2017 Jun 28;8(38):63461-63483 [PMID: 28969005]
  20. Front Neurol. 2020 May 28;11:402 [PMID: 32547470]
  21. Biophys J. 2005 Aug;89(2):1302-7 [PMID: 15894637]
  22. Cancer Res. 2013 Jan 15;73(2):672-82 [PMID: 23243021]
  23. Cancer Lett. 2015 Nov 1;368(1):7-13 [PMID: 26276713]
  24. J Biomech. 2010 May 7;43(7):1279-86 [PMID: 20185132]
  25. Cell Mol Bioeng. 2010 Sep 1;3(3):296-306 [PMID: 21076644]
  26. Annu Rev Biomed Eng. 2014 Jul 11;16:321-46 [PMID: 25014786]
  27. PLoS One. 2015 Mar 23;10(3):e0117495 [PMID: 25798887]
  28. Gastroenterology. 2016 Apr;150(4):1033-5 [PMID: 26922869]
  29. Antimicrob Agents Chemother. 1989 Aug;33(8):1286-90 [PMID: 2802555]
  30. Sci Rep. 2018 Jul 9;8(1):10340 [PMID: 29985427]
  31. Ann Biomed Eng. 2017 Apr;45(4):1027-1038 [PMID: 27770219]
  32. Semin Cancer Biol. 2015 Feb;30:60-9 [PMID: 24657638]
  33. Cancer Res. 2015 Jun 1;75(11):2151-8 [PMID: 25855383]
  34. J Immunol. 2018 Jul 1;201(1):278-295 [PMID: 29752311]
  35. Nanomedicine. 2018 Jan;14(1):195-204 [PMID: 28982587]
  36. Genome Med. 2018 Mar 26;10(1):23 [PMID: 29580275]
  37. Cancer Res. 2013 Nov 15;73(22):6609-20 [PMID: 24085788]
  38. Biophys J. 2002 Sep;83(3):1650-60 [PMID: 12202388]
  39. J Theor Biol. 2007 Apr 21;245(4):677-704 [PMID: 17239903]
  40. Ann Biomed Eng. 2012 Nov;40(11):2425-41 [PMID: 22565817]
  41. Cancer Res. 2000 May 1;60(9):2497-503 [PMID: 10811131]
  42. J Immunol. 2017 Aug 15;199(4):1505-1515 [PMID: 28696255]
  43. Nat Cell Biol. 2015 Jun;17(6):816-26 [PMID: 25985394]
  44. Processes (Basel). 2019 Jan;7(1): [PMID: 30701168]

Grants

  1. R01 CA184770/NCI NIH HHS

Word Cloud

Created with Highcharts 10.0.0transportcellsTMEexosomeinterstitialtumorexosomesfluidflowreleaseforceconcentrationcancerdiffusionratestranswell4T12oscillatoryexosome-mediatedincludingpressuremodelsstudyusingdueusedseededexposedExosomesimulationslargertwostagesgrowthComputationalcomputationalCellularcrosstalkmicroenvironmentcriticalcomponentanti-tumorimmuneresponsesadditionparticlesizeuptaketargetinfluencedphysicalphysiologicalfactorsvariablesdiffernormalpathologicalconditionsgovernedBaseddeterminantsmathematicaladaptedsimulatespecifiedsignificancespatialrelationshipintercellularcommunicationestablishedtreatingmovementcontinuumequationadvectiongradientsquantifyratebiomechanicalforcesactingplatformconfluenttriplenegativebreastBioFlexplatesquantifiedbottomwellfollowingapplicationeithermodelpredictednumberreachedmembranecomparedcontrolsAdditionallysimulated2-dimensionalmacrophagesTmixturespopulationsdifferentcarriedcommercialsimulationpackageANSYS/FluentresultsindicatedhigherconcentrationslaterQuantifyingwillafforddeeperunderstandingmechanismsinteractionsaidderivingpredictivetherapeuticinterventionSimulationTransportTumorMicroenvironmentmodelingequations

Similar Articles

Cited By